Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer

被引：0
|
作者：
Shengri Liao
Bill C. Penney
Kristen Wroblewski
Hao Zhang
Cassie A. Simon
Rony Kampalath
Ming-Chi Shih
Naoko Shimada
Sheng Chen
Ravi Salgia
Daniel E. Appelbaum
Kenji Suzuki
Chin-Tu Chen
Yonglin Pu
机构：
[1] University of Chicago,Department of Radiology, MC 2026
[2] University of Chicago,Department of Health Studies, MC 2007
[3] University of Chicago,Cancer Registry, MC 0957
[4] University of Chicago,Chest Oncology, MC 2115
[5] Peking University Cancer Hospital & Institution,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)
[6] First Hospital of Lanzhou University,Department of Radiology
[7] Juntendo University School of Medicine,Department of Respiratory Medicine
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2012年 / 39卷
关键词：
F-FDG; Non-small cell lung cancer; Tumor burden; Metabolic tumor volume; Total lesion glycolysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：27 / 38
页数：11
相关论文
共 50 条
  • [41] Tumor heterogeneity measurement using [18F] FDG PET/CT shows prognostic value in patients with non-small cell lung cancer
    Hughes N.M.
    Mou T.
    O’Regan K.N.
    Murphy P.
    O’Sullivan J.N.
    Wolsztynski E.
    Huang J.
    Kennedy M.P.
    Eary J.F.
    O’Sullivan F.
    European Journal of Hybrid Imaging, 2 (1):
  • [42] Integrated 18F-FDG PET/CT parameter defines metabolic oligometastatic non-small cell lung cancer
    Ma, Rong
    Zhao, Qian
    Zhao, Ren
    Li, Juan
    Wang, Yan-Yang
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (09) : 1026 - 1033
  • [43] Prognostic value of primary tumor SUVmax on pre-treatment 18F-FDG PET/CT imaging in patients with stage III non-small cell lung cancer
    Yilmaz, U.
    Batum, O.
    Koparal, H.
    Ozbilek, E.
    Kirakli, E.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2018, 37 (04): : 218 - 222
  • [44] The prediction of response to immunotherapy in non-small cell lung cancer patients by 18F-FDG PET/CT
    Evangelista, Laura
    JOURNAL OF THORACIC DISEASE, 2019, 11 (11) : E221 - E223
  • [45] Role of 18F-FDG PET/CT in radiotherapy planning for patients with non-small cell lung cancer
    Garcia-Talavera, P.
    Matias-Perez, A.
    Cigarrol, C.
    Gomez-Caminero, F.
    Perez-Romasanta, L. A.
    Martin, M. E.
    Martin, E.
    Perez, B.
    Tamayo, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S485 - S485
  • [46] Prognostic Value of Metabolic Parameters in patients with lung cancer determined by 18F-FDG and 18F-FAMT-PET
    Kumasaka, S.
    Arisaka, Y.
    Nakajima, T.
    Fukushima, Y.
    Tokue, A.
    Kim, M.
    Higuchi, T.
    Tsushima, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S336 - S336
  • [47] Visual Versus Quantitative Assessment of Intratumor 18F-FDG PET Uptake Heterogeneity: Prognostic Value in Non-Small Cell Lung Cancer
    Tixier, Florent
    Hatt, Mathieu
    Valla, Clemence
    Fleury, Vincent
    Lamour, Corinne
    Ezzouhri, Safaa
    Ingrand, Pierre
    Perdrisot, Remy
    Visvikis, Dimitris
    Le Rest, Catherine Cheze
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (08) : 1235 - 1241
  • [48] 18F-FDG PET in planning radiation treatment of non-small cell lung cancer:: Where exactly is the tumor?
    Dahele, Max R.
    Ung, Yee C.
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (08) : 1402 - 1402
  • [49] Predictive value of multiple metabolic and heterogeneity parameters of 18F-FDG PET/CT for EGFR mutations in non-small cell lung cancer
    Shi, Aiqi
    Wang, Jianling
    Wang, Yuzhu
    Guo, Guorong
    Fan, Chouchou
    Liu, Jiangyan
    ANNALS OF NUCLEAR MEDICINE, 2022, 36 (04) : 393 - 400
  • [50] Predictive value of multiple metabolic and heterogeneity parameters of 18F-FDG PET/CT for EGFR mutations in non-small cell lung cancer
    Aiqi Shi
    Jianling Wang
    Yuzhu Wang
    Guorong Guo
    Chouchou Fan
    Jiangyan Liu
    Annals of Nuclear Medicine, 2022, 36 : 393 - 400
12345